Addition of Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to an Education and Exercise Program in Subjects With Chronic Pain Due to Knee Osteoarthritis
1 other identifier
interventional
65
1 country
1
Brief Summary
Knee osteoarthritis has a very high prevalence in the population over 50 years of age. Patients with osteoarthritis often suffer from chronic pain that becomes disabling, affecting both quality of life and mental and physical health. This pathology has also been linked to maladaptive plasticity in the brain, which can contribute to chronic pain. Therapies with neuromodulatory approaches, such as transcranial direct current stimulation (tDCS) and peripheral electrical stimulation (TENS), have been used therapeutically to counteract the maladaptive plasticity of the brain. Transcranial therapy and TENS can be a possible effective treatment in the rehabilitation services of the health system for the improvement of chronic pain and quality of life in different pathologies, such as chronic low back pain, fibromyalgia or knee and hip osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2021
CompletedStudy Start
First participant enrolled
November 17, 2021
CompletedFirst Posted
Study publicly available on registry
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedMay 8, 2024
January 1, 2024
2.3 years
October 4, 2021
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Chronic Knee Pain
The Visual Analogic Scale will be used to assess the impact on chronic knee pain. The values range from 0 to 10 (0 = No pain, 10 = the worst pain).
Through study completion, an average of 1 year.
Secondary Outcomes (9)
Function and Quality of Life
Through study completion, an average of 1 year.
Force
Through study completion, an average of 1 year.
Balance
Through study completion, an average of 1 year.
Gait properties.
Through study completion, an average of 1 year.
Coordination and Balance
Through study completion, an average of 1 year.
- +4 more secondary outcomes
Study Arms (3)
tDCS Active vs TENS Active
EXPERIMENTALtDCS Active vs TENS Placebo
EXPERIMENTALtDCS Placebo vs TENS Placebo
PLACEBO COMPARATORInterventions
tDCS intervention will consist in placing two electrodes, the cathode on the supraorbital surface on the same side as the painful knee, and the anode on the parietal area, corresponding to the area of the primary motor cortex, on the opposite side. The intensity will be 2 milli amperes (mA) and stimulation will be 20 minutes. The placebo will generate an initial sensation, and then descend until the stimulation is turned off.
TENS intervention will consist in placing two electrodes on the sides of the patella of the affected knee. The frequency will be 10Herzts and the intensity will remain at a sensitive threshold level, without reaching the motor. The placebo will generate a sensation of current to descend to the minimum value that the equipment allows. Stimulation will last for 20 minutes.
The General Education Intervention consisting in an educational program will be applied to all groups using audiovisual material to increase the subject's knowledge about his/her pathology, about chronic pain and recommendations for supervised exercise based on the NEMEX protocol for osteoarthritis (Ageberg et al.)18: the participants will be taught analytical strengthening exercises (quadriceps and hamstrings) and neuromuscular functional exercises (getting up from the chair or going up a step), with their detailed dosage (2 to 3 series with 10 to 15 repetitions) and a home follow-up model where the participant must record compliance with exercise as well as pain during activity.
Eligibility Criteria
You may qualify if:
- Adults over fifty years of age with a diagnosis of knee osteoarthritis by radiography.
- Chronic pain of more than six months, compliance with the diagnostic criteria for knee osteoarthritis according to the Osteoarthritis Research Society International (OARSI) guideline:
- Pain in Analog Visual Scale more than 4/10
- Matutinal less than 30 minutes
- Absence of hyperthermia upon palpation in the joint
- Alteration of the bone image
- Crepitus
You may not qualify if:
- Patients who can provide low-quality or biased information discriminated by the Mini-Mental State Examination (Score less than 24).
- Severe hearing, visual or sensory impairment or comorbidities that prevent the correct completion of the questionnaires and mobility activities.
- Patients who have undergone knee replacement surgery on the contralateral knee.
- Patients who have received intervention (infiltration, blockages, etc...) in the last 6 weeks.
- Pain due to tendinopathy, knee fracture, low back pain radiating to the knee, or fibromyalgia.
- Patients who decline to participate out of fear or denial of therapy.
- Severe heart disease that prevent exercise.
- Body Mass Index above 45.
- Patients with neuropsychiatric disorders (schizophrenia, epilepsy or bipolar disorders) or taking medication for these conditions (antiepileptic drugs).
- Patients with metallic implants in the area (skull or knee).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Murcia
Murcia, 30100, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Joaquina JM Montilla, PhD, PT
Director
- STUDY DIRECTOR
Mariano MG Gacto, PhD, PT
Co-Director
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2021
First Posted
December 1, 2021
Study Start
November 17, 2021
Primary Completion
March 1, 2024
Study Completion
May 1, 2024
Last Updated
May 8, 2024
Record last verified: 2024-01